The transcription factor NFAT4 is involved in the generation and survival of T cells

Immunity

Volumn 9, Issue 3, 1998, Pages 295-304

  Oukka, Mohamed ^a   Ho, I Cheng ^a   Charles De La Brousse, Fabienne ^c   Hoey, Timothy ^c   Grusby, Michael J ^a   Glimcher, Laurie H ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN BCL 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; EARLY RESPONSE GENE; FLOW CYTOMETRY; IMMUNOBLOTTING; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE;

EID: 0032167830     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80612-3     Document Type: Article

References (75)

1. Akashi, K., Kondo, M., von Freeden-Jeffry, U., Murray, R., and Weissman, I.L. (1997). Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89, 1033-1041.
2. Alberola-Ila, J., Forbush, K.A., Seger, R., Krebs, E.G., and Perlmutter, R.M. (1995). Selective requirement for MAP kinase activation in thymocyte differentiation. Nature 373, 620-623.
3. Alberola-Ila, J., Hogquist, K.A., Swan, K.A., Sevan, M.J., and Perlmutter, R.M. (1996). Positive and negative selection invoke distinct signaling pathways. J. Exp. Med. 184, 9-18.
4. Amasaki, Y., Masuda, E.S., Imamura, R., Arai, K.-I., and Arai, N. (1998). Distinct NFAT family proteins are involved in the nuclear NFAT-DNA binding complexes from human thymocyte subsets. J. Immunol. 160, 2324-2333.
5. + thymocytes in vitro. J. Immunol. 154, 3636-3643.
6. Beals, C.R., Clipstone, N.A., Ho, S.N., and Crabtree, G.R. (1997a). Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev. 11, 824-834.
7. Beals, C.R., Sheridan, C.M., Turck, C.W., Gardner, P., and Crabtree, G.R. (1997b). Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275, 1930-1933.
8. Bevan, M.J. (1997). In thymic selection, peptide diversity gives and takes away. Immunity 7, 175-178.
9. Boise, L.H., Petryniak, B., Mao, X., June, C. H., Wang, C.-Y., Lindsten, T., Bravo, R., Kovary, K., Leiden, J.M., and Thompson, C.B. (1993). The NFAT-1 DN A binding complex in activated T cells contains Fra-1 and JunB. Mol. Cell. Biol. 13, 1911-1919.
10. Brady, H J.M., Gil-Gómez, G., Kirberg, J., and Berns, A.J.M. (1996). Baxa perturbs T cell development and affects cell cycle entry of T cells. EMBO J. 15, 6991-7001.
11. Chow, C.-W., Rincón, M., Cavanagh, J., Dickens, M., and Davis, R.J. (1997). Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science 278, 1638-1641.
12. Clipstone, N.A., and Crabtree, G.R. (1992). Identification of calcineurin as a key signaling enzyme in T-lymphocyte activation. Nature 357, 695-697.
13. Cockerill, P.N., Shannon, M.F., Bert, A.G., Ryan, G.R., and Vadas, M.A. (1993). The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc. Natl. Acad. Sci. USA 90, 2466-2470.
14. Cory, S. (1995). Regulation of lymphocyte survival by the BCL-2 gene family. Annu. Rev. Immunol. 13, 513-543.
15. Crabtree, G. (1989). Contingent genetic regulatory events in T lymphocyte activation. Science 249, 355-360.
16. 2+ re-sponse amplitude and duration. Nature 386, 855-858.
17. Durand, D., Shaw, J., Bush, M., Replogle, R., Belagaje, R., and Crabtree, G. (1988). Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8, 1715-1724.
18. Emmel, E.A., Verweij, C.L., Durand, D.B., Higgins, K.M., Lacy, E., and Crabtree, G.R. (1989). Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science 246, 1617-1620.
19. Fischer, K.-D., Kong, Y.-Y., Nishina, H., Tedford, K., Marengère, L.E.M., Kozieradzki, I., Sasaki, T., Starr, M., Chan, G., Gardener, S., et al. (1998). Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr. Biol. 8, 554-562.
20. Flanagan, W.M., Corthesy, B., Bram, R.J., and Crabtree, G.R. (1991). Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352, 803-807.
21. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S.A. (1992). Identification of programmed cell death in situ via specific labeling of nucleic DNA fragmentation. J. Cell Biol. 119, 493-501.
22. Gorczyca, W., Bruno, S., Darzynkiewicz, R.J., Gong, J., and Darzynkiewicz, Z. (1992). DNA strand breaks occurring during apoptosis: their early in situ detection by terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int. J. Oncol. 1, 639-648.
23. Gratiot-Deans, J., Merino, R., Nuñez, G., and Turka, L.A. (1994). Bcl-2 expression during T-cell development: early loss and late return occur at specific stages of commitment to differentiation and survival. Proc. Natl. Acad. Sci. USA 91, 10685-10689.
24. Gulbins, E., Coggeshall, K.M., Baier, G., Katzav, S., Burn, P., and Altman, A. (1993). Tyrosine kinase-stimulated guanine nucleotide exchange activity of vav in T cell activation. Science 260, 822-825.
25. Ho, I.-C., Hodge, M.R., Rooney, J.W., and Glimcher, L.H. (1996). The proto-oncogenec-maf is responsible for tissue-specific expression of interleukin-4. Cell 85, 973-983.
26. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D., and Korsmeyer, S.J. (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336.
27. Hockenbery, D.M., Oltvai, Z.N., Yin, X.-M., Milliman, C.L., and Korsmeyer, S.J. (1993). Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
28. Hodge, M.R., Chun, H.J., Rengarajan, J., Alt, A., Lieberson, R., and Glimcher, L.H. (1996a). NFAT-driven interleukin-4 transcription potentiated by NIP45. Science 274, 1903-1905.
29. Hodge, M.R., Ranger, A.M., Charles de la Brousse, F., Hoey, T., Grusby, M.J., and Glimcher, L.H. (1996b). Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4, 397-405.
30. Hoey, T., Sun, Y.-L., Williamson, K., and Xu, X. (1995). Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity 2, 461-472.
31. Holsinger, L.J., Graef, I.A., Swat, W., Chi, T., Bautista, D.M., Davidson, L., Lewis, R.S., Alt, F.W., and Crabtree, G.R. (1998). Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 8, 563-572.
32. Jacobson, M.D. (1997). Apoptosis: Bcl-2-related proteins get connected. Curr. Biol. 7, R277-R281.
33. Jain, J., McCaffrey, P.G., Valge-Archer, V.E., and Rao, A. (1992). Nuclear factor of activated T cells contains Fos and Jun. Nature 356, 801-804.
34. Jain, J., McCaffrey, P.G., Miner, Z., Kerppola, T.K., Lambert, J.N., Verdine, G.L., Curran, T., and Rao, A. (1993). The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365, 352-355.
35. Jenkins, M.K., Schwartz, R.H., and Pardoll, D.M. (1988). Effects of cyclosporine A on T cell development and clonal deletion. Nature 336, 1655-1658.
36. Kizaki, H., Tadakuma, T., Odaka, C., Muramatsu, J., and Ishimura, Y. (1989). Activation of a suicide process of thympoctes through DNA fragmentation by calcium ionophores and phorbol esters. J. Immunol. 743, 1790-1794.
37. Knudson, C.M., and Korsmeyer, S.J. (1997). Bcl-2 and Bax function independently to regulate cell death. Nat. Genet. 16, 358-363.
38. Kondo, M., Akashi, K., Domen, J., Sugamura, K., and Weissman, I.L. (1997). Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common γ chain-deficient mice. Immunity 7, 155-162.
39. Leonard, W.J. (1996). The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling. Annu. Rev. Med. 47, 229-239.
40. + stageduring positive selection and promotes thymocyte differentiation at several control points. Immunity 1, 197-205.
41. -1- mice. Cell 89, 1011-1019.
42. Masuda, E.S., Naito, Y., Tokumitsu, H., Campbell, D., Saito, F., Hannum, C., Arai, K.-I., and Arai, N. (1995). NFATx, a novel member of the nuclear factor of activated T cells family that is expressed predominantly in the thymus. Mol. Cell. Biol. 15, 2697-2706.
43. McCaffrey, P.G., Luo, C., Kerppola, T.K., Jain, J., Badalian, T.M., Ho, A.M., Burgeon, E., Lane, W.S., Lambert, J.N., Curran, T., et al. (1993). Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science 262, 750-754.
44. Murphy, D.B., Lo, D., Rath, S., Brinster, R.L., Flavell, R.A., Slanetz, A., and Janeway, C.A., Jr. (1989). A novel MHC class II epitope expressed in thymic medulla but not cortex. Nature 338, 765-768.
45. Nakajima, H., Shores, E.W., Noguchi, M., and Leonard, W.J. (1997). The common cytokine receptor γ chain plays an essential role in regulating lymphoid homeostasis. J. Exp. Med. 185, 189-195.
46. Negrini, M., Silini, E., Kozak, C., Tsujimoto, Y., and Grace, C.M. (1987). Molecular analysis of mbcl-2: structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma. Cell 49, 455-463.
47. Northrop, J.P., Ho, S.N., Chen, L., Thomas, D.J., Timmerman, L.A., Nolan, G.P., Admon, A., and Crabtree, G.R. (1994). NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369, 497-502.
48. + thymocytes. Immunity 7, 243-254.
49. + thymocytes in the presence of cyclosporin A. Devel. Immunol. 5, 1-15.
50. Ranger, A.M., Hodge, M.R., Gravallese, E.M., Oukka, M., Davidson, L., Alt, F.W., Charles de la Brousse, F., Hoey, T., Grusby, M., and Glimcher, L.H. (1998a). Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 8, 125-134.
51. Ranger, A.M., Grusby, M.J., Hodge, M.R., Gravallese, E.M., Charles de la Brousse, F., Hoey, T., Mickanin, C., Baldwin, H.S., and Glimcher, L.H. (1998b). The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392, 186-190.
52. Rao, A., Luo, C., and Hogan, P.G. (1997). Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707-747.
53. Reed, J.C. (1997). Double identity for proteins of the Bcl-2 family. Nature 387, 773-776.
54. Rincón, M., and Flavell, R.A. (1996). Regulation of AP-1 and NFAT transcription factors during thymic selection of T cells. Mol. Cell. Biol. 16, 1074-1084.
55. Rooney, J., Sun, Y.-L., Glimcher, L.H., and Hoey, T. (1995a). Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol. Cell. Biol. 15, 6299-6310.
56. Rooney, J.W., Hoey, T., and Glimcher, L.H. (1995b). Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity 2, 473-483.
57. Shao, H., Kono, D.H., Chen, L.-Y., Rubin, E.M., and Kaye, J. (1997). Induction of the early growth response (Egr) family of transcription factors during thymic selection. J. Exp. Med. 185, 731-744.
58. Shaw, J., Utz, P., Durand, D., Toole, J., Emmel, E., and Crabtree, G. (1988). Identification of a putative regulator of early T cell activation genes. Science 241, 202-205.
59. Strasser, A., Harris, A.W., and Cory, S. (1991). Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67, 889-899.
60. Strasser, A., Harris, A.W., Corcoran, L.M., and Cory, S. (1994a). Bcl-2 expression promotes B but not T-lymphoid development in scid mice. Nature 368, 457-460.
61. Strasser, A., Harris, A.W., von Boehmer, H., and Cory, S. (1994b). Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a Bcl-2transgene. Proc. Natl. Acad. Sci. USA 91, 1376-1380.
62. Takahashi, T., Tanaka, M., Brannan, G.I., Jenkins, N.A., Copeland, N.G., Suda, T., and Nagata, S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
63. Thomis, D.C., and Berg, L.J. (1997). Peripheral expression of Jak3 is required to maintain T lymphocyte function. J. Exp. Med. 185, 197-206.
64. Thompson, C. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
65. Timmerman, L.A., Healy, J.I., Ho, S.N., Chen, L., Goodnow, G.G., and Crabtree, G.R. (1997). Redundant expression but selective utilization of nuclear factor of activated T cells family members. J. Immunol. 159, 2735-2740.
66. Turner, H., and Cantrell, D.A. (1997). Distinct Ras effector pathways are involved in Fc∈R1 regulation of the transcriptional activity of Elk-1 and NFAT in mast cells. J. Exp. Med. 185, 43-53.
67. Turner, M., Mee, P.J., Walters, A.E., Quinn, M.E., Mellor, A.L., Zamoyska, R., and Tybulewicz, V.L.J. (1997). A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 7, 451-460.
68. Vaux, D.L., Cory, S., and Adams, J.M. (1988). Bcl-2 gene promotes haemopoieticcell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440-442.
69. Veis, D.J., Sentman, C.L., Bach, E.A., and Korsmeyer, S.J. (1993a). Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J. Immunol. 151, 2546-2554.
70. Veis, D.J., Sorenson, C.M., Shutter, J.R., and Korsmeyer, S.J. (1993b). Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229-240.
71. von Boehmer, H. (1997). T-cell development: is Notch a key player in lineage decisions? Curr. Biol. 7, R308-R310.
72. + thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection. J. Exp. Med. 181, 927-941.
73. Washburn, T., Schweighoffer, E., Gridley, T., Chang, D., Fowlkes, B.J., Cado, D., and Robey, E. (1997). Notch activity influences the αβ vs. γδ T cell lineage decision. Cell 88, 833-843.
74. vav activity. Mol. Cell. Biol. 15, 4337-4346.
75. Xanthoudakis, S., Viola, J.P.B., Shaw, K.T.Y., Luo, C., Wallace, J.D., Bozza, P.T., Luk, D.C., Curran, T., and Rao, A. (1996). An enhanced immune response in mice lacking the transcription factor NFAT1. Science 272, 892-895.